{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:45:43Z","timestamp":1787802343173,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR066765"],"award-info":[{"award-number":["R01 AR066765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-37913"],"award-info":[{"award-number":["MOP-37913"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.celrep.2023.112578","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T23:10:46Z","timestamp":1685661046000},"page":"112578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation"],"prefix":"10.1016","volume":"42","author":[{"given":"Sinthu","family":"Pathmanapan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasa Barrientos","family":"De Renshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puviindran","family":"Nadesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gireesh A.","family":"Seesankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian Kwan Ho","family":"Loe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan J.","family":"Guinovart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Newgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Wunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-122X","authenticated-orcid":false,"given":"Benjamin A.","family":"Alman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112578_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00264-006-0212-x","article-title":"Pathology of primary malignant bone and cartilage tumours","volume":"30","author":"Rozeman","year":"2006","journal-title":"Int. Orthop."},{"key":"10.1016\/j.celrep.2023.112578_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc2869","article-title":"Cartilage tumours and bone development: molecular pathology and possible therapeutic targets","volume":"10","author":"Bov\u00e9e","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2023.112578_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biocel.2007.06.009","article-title":"Endochondral ossification: how cartilage is converted into bone in the developing skeleton","volume":"40","author":"Mackie","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.celrep.2023.112578_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-020-00639-7","article-title":"Enchondromatosis and growth plate development","volume":"19","author":"Zhang","year":"2021","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.celrep.2023.112578_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/B978-0-12-821666-8.00020-7","article-title":"Biology of cartilage tumor family","author":"Hiemcke-Jiwa","year":"2022","journal-title":"Bone Cancer"},{"key":"10.1016\/j.celrep.2023.112578_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng844","article-title":"A mutant PTH\/PTHrP type I receptor in enchondromatosis","volume":"30","author":"Hopyan","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2023.112578_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","article-title":"Constitutive Hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation","volume":"168","author":"Tiet","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2023.112578_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2007-0237","article-title":"The clinical approach towards chondrosarcoma","volume":"13","author":"Gelderblom","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.celrep.2023.112578_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41416-018-0050-9","article-title":"Targeting glutaminolysis in chondrosarcoma in context of the IDH1\/2 mutation","volume":"118","author":"Peterse","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2023.112578_bib10","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1073\/pnas.1424400112","article-title":"Mutant IDH is sufficient to initiate enchondromatosis in mice","volume":"112","author":"Hirata","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112578_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.celrep.2023.112578_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2014.1205","article-title":"IDH mutation in glioma: new insights and promises for the future","volume":"71","author":"Turkalp","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2023.112578_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41588-017-0001-z","article-title":"Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence","volume":"50","author":"Turcan","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2023.112578_bib14","doi-asserted-by":"crossref","first-page":"12505","DOI":"10.18632\/oncotarget.3723","article-title":"Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines","volume":"6","author":"Suijker","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2023.112578_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-013-1106-9","article-title":"What do we know about IDH1\/2 mutations so far, and how do we use it?","volume":"125","author":"Horbinski","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2023.112578_bib16","doi-asserted-by":"crossref","first-page":"e0133813","DOI":"10.1371\/journal.pone.0133813","article-title":"Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112578_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13569-017-0074-6","article-title":"IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas","volume":"7","author":"Cleven","year":"2017","journal-title":"Clin. Sarcoma Res."},{"key":"10.1016\/j.celrep.2023.112578_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1200\/JCO.19.02492","article-title":"Phase I study of the mutant IDH1 inhibitor Ivosidenib: safety and clinical activity in patients with advanced chondrosarcoma","volume":"38","author":"Tap","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2023.112578_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40170-021-00247-8","article-title":"Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes","volume":"9","author":"Pathmanapan","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.celrep.2023.112578_bib20","series-title":"Normal Bone Formation","first-page":"136","article-title":"Normal bone formation","author":"Brighton","year":"1978"},{"key":"10.1016\/j.celrep.2023.112578_bib21","first-page":"1165","article-title":"Presence of glycogen and growth\u2013related variations in 58 cultured huma tumor cell lines of various tissue origins","volume":"41","author":"Rousset","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2023.112578_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fonc.2012.00018","article-title":"Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival","volume":"2","author":"Pelletier","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2023.112578_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cmet.2012.10.017","article-title":"Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells","volume":"16","author":"Favaro","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2023.112578_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cmet.2019.08.014","article-title":"Nuclear glycogenolysis modulates histone acetylation in human non-small cell lung cancers","volume":"30","author":"Sun","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2023.112578_bib25","doi-asserted-by":"crossref","first-page":"e9644","DOI":"10.1371\/journal.pone.0009644","article-title":"Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1","volume":"5","author":"Pescador","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112578_bib26","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4161\/cc.9.17.12908","article-title":"HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: autophagy drives compartment-specific oncogenesis","volume":"9","author":"Chiavarina","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.celrep.2023.112578_bib27","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-019-12525-7","article-title":"Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression","volume":"10","author":"Nicolle","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112578_bib28","series-title":"E-MTAB-7265 - High-Throughput Sequencing of miRNA of Cartilage Tumors","author":"Nabila","year":"2018"},{"key":"10.1016\/j.celrep.2023.112578_bib29","series-title":"Identification of Glycogen of Thin Tissue in Electron Sections","author":"Revel","year":"1960"},{"key":"10.1016\/j.celrep.2023.112578_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2018.08.007","article-title":"Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis","volume":"29","author":"Curtis","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2023.112578_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.trecan.2017.09.007","article-title":"The glycogen shunt maintains glycolytic homeostasis and the Warburg effect in cancer","volume":"3","author":"Shulman","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.celrep.2023.112578_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gendis.2017.02.003","article-title":"Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment","volume":"4","author":"Jiang","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.celrep.2023.112578_bib33","series-title":"The Metabolism of Tumours: Investigations from the Kaiser Wilhelm Institute for Biology","author":"Warburg","year":"1930"},{"key":"10.1016\/j.celrep.2023.112578_bib34","first-page":"397","article-title":"The metabolism of tumors in the body","volume":"309","author":"Otto Warburg","year":"1923","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.celrep.2023.112578_bib35","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1073\/pnas.95.4.1776","article-title":"Discovery of a human liver glycogen phosphorylase inhibitor that lowers Blood glucose in\u00a0vivo","volume":"95","author":"Martin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112578_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fbioe.2016.00012","article-title":"In\u00a0vitro tumor models: advantages, disadvantages, variables, and selecting the right platform","volume":"4","author":"Katt","year":"2016","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.celrep.2023.112578_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jbmr.4532","article-title":"Distinct roles of glutamine metabolism in benign and malignant cartilage tumors with IDH mutations","volume":"37","author":"Zhang","year":"2022","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.celrep.2023.112578_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2023.112578_bib39","doi-asserted-by":"crossref","first-page":"e0133813","DOI":"10.1371\/journal.pone.0133813","article-title":"Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112578_bib40","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1038\/s41388-019-0929-9","article-title":"Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma","volume":"38","author":"Nakagawa","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2023.112578_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acsmedchemlett.7b00421","article-title":"Discovery of AG-120 (Ivosidenib): a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers","volume":"9","author":"Popovici-Muller","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.celrep.2023.112578_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jor.21193","article-title":"Increased levels of hypoxia-inducible factor-1\u03b1 are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma","volume":"29","author":"Chen","year":"2011","journal-title":"J.\u00a0Orthop. Res."},{"key":"10.1016\/j.celrep.2023.112578_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.celrep.2023.112578_bib45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.8.3.719","article-title":"Chondrogenesis, studied with the electron microscope","volume":"8","author":"Godman","year":"1960","journal-title":"J.\u00a0Biophys. Biochem. Cytol."},{"key":"10.1016\/j.celrep.2023.112578_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11914-019-00506-0","article-title":"The emerging role of glucose metabolism in cartilage development","volume":"17","author":"Hollander","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.celrep.2023.112578_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1078\/0065-1281-00604","article-title":"Immunocytochemical demonstration of glucose transporters in epiphyseal growth plate chondrocytes of young rats in correlation with autoradiographic distribution of 2-deoxyglucose in chondrocytes of mice","volume":"103","author":"Ohara","year":"2001","journal-title":"Acta Histochem."},{"key":"10.1016\/j.celrep.2023.112578_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1097-4652(199906)179:3<287::AID-JCP6>3.0.CO;2-T","article-title":"Chondrocyte death is linked to development of a mitochondrial membrane permeability transition in the growth plate","volume":"179","author":"Rajpurohit","year":"1999","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.celrep.2023.112578_bib50","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1210\/en.2010-1412","article-title":"Deletion of glycogen synthase kinase-3 in cartilage results in up-regulation of glycogen synthase kinase-3 protein expression","volume":"152","author":"Gillespie","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2023.112578_bib51","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/neuonc\/not015","article-title":"Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing","volume":"15","author":"Agarwal","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2023.112578_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","article-title":"Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors","volume":"20","author":"Capper","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.celrep.2023.112578_bib53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/NEN.0b013e31822713f0","article-title":"Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens","volume":"70","author":"Preusser","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.celrep.2023.112578_bib64","unstructured":"European Bioinformatics Institute database (EMBL-EBI)."},{"key":"10.1016\/j.celrep.2023.112578_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/jcbfm.2012.200","article-title":"Impairment in long-term memory formation and learning-dependent synaptic plasticity in mice lacking glycogen synthase in the brain","volume":"33","author":"Duran","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.celrep.2023.112578_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature11323","article-title":"IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics","volume":"488","author":"Sasaki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112578_bib56","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1242\/dev.128.24.5099","article-title":"Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation","volume":"128","author":"Long","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.celrep.2023.112578_bib57","first-page":"513","article-title":"Generation of a transgenic mouse model with chondrocyte- specific and tamoxifen-inducible expression of Cre recombinase","volume":"17","author":"Crotti","year":"2014","journal-title":"Genesis"},{"key":"10.1016\/j.celrep.2023.112578_bib58","first-page":"4010","article-title":"Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth","volume":"60","author":"Ryan","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2023.112578_bib59","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz- scid IL2R \u03b3 null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112578_bib60","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1158\/0008-5472.CAN-07-0999","article-title":"Side population cells isolated from mesenchymal neoplasms have tumor initiating potential","volume":"67","author":"Wu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2023.112578_bib61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z","article-title":"Characterization of a newly derived human sarcoma cell line (HT-1080)","volume":"33","author":"Rasheed","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.celrep.2023.112578_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3835(96)04274-7","article-title":"Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas","volume":"105","author":"Jagasia","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2023.112578_bib63","doi-asserted-by":"crossref","unstructured":"Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, Arbiser J L, Apperley J F Interleukin-1,8-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94 2307-2316","DOI":"10.1172\/JCI117595"},{"key":"10.1016\/j.celrep.2023.112578_bib65","doi-asserted-by":"crossref","first-page":"e127232","DOI":"10.1172\/jci.insight.127232","article-title":"Intracellular cholesterol biosynthesis in enchondroma and chondrosarcoma","volume":"5","author":"Zhang","year":"2019","journal-title":"JCI Insight"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723005892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723005892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T22:28:30Z","timestamp":1720736910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723005892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2211124723005892"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112578","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"112578"}}